Development and maturation of natural killer cells
Introduction
NK cells, like B and T cells, are a lymphocyte lineage derived from the CLP [1], and like B cells, are thought to develop primarily in the bone marrow [2], although other sites of development, such as the liver and thymus, have also been proposed (reviewed in [3]). However, unlike the antigen receptors of B and T cells, NK cell receptors are germ line encoded and do not require gene rearrangement by RAG recombinase [4], though recent work has suggested that RAG plays an unexpected cell-intrinsic role in NK cell development [5••]. NK cells also undergo an ‘education’ process during development where they acquire the ability to recognize lack of self MHC class I, or ‘missing-self’, a feature that facilitates their surveillance of target cells that have down-regulated MHC class I during infection or malignancy [6]. NK cells rely on both cytokines and transcription factors to promote and control their development. Cytokine signaling from interleukin (IL)-15 is critical for the development of NK cells and is required throughout their lifetime [7, 8]. Transcription factors such as Nfil3 and PU.1 are necessary for development of early NK cell progenitors [9, 10, 11, 12], whereas Id2, Tox, and others are important later in development [13, 14, 15]. Eomes and T-bet are among factors that then control the final stages of NK cell maturation [16, 17]. In the periphery, the activation and differentiation of NK cells are regulated by a plethora of transcription factors mediating distinct effector functions. This review will outline current knowledge about the stages of NK cell development and the factors driving each stage.
Section snippets
Stages of NK cell development and differentiation
The CLP is characterized by expression of IL-7Rα (CD127), c-kit (CD117), Sca-1, and Flt-3 (CD135), as well as the lack of common lineage markers such as CD3, CD4, CD8, CD19, Ter119, Gr-1 and NK1.1 (Figure 1) [1]. From the CLP, cells develop into NK cell precursors (NKP), which are defined by expression of the IL-15 receptor β chain (CD122), and lack of common lineage markers, including the NK cell markers NK1.1 and DX5 (CD49b) (Figure 1) [2]. This NKP population has been further refined based
Transcriptional control of early NK cell development
Lineage commitment to either an adaptive or innate lymphocyte cell fate is determined by a complex network of transcription factors (Figure 2). For example, Notch signaling through the ligands Jagged1 and Jagged2 preferentially drives NK cell development from the CLP [28, 29, 30], whereas delta-like ligands (DLL) promote T cell development [31]. Moreover, thymocytes can be diverted into an NK cell-like fate if the Notch1-dependent transcription factor Bcl11b is ablated during T cell development
Transcription factors governing NK cell maturation
In addition to the early role for Id family transcription factors in suppressing the adaptive lymphocyte fate while promoting innate lymphocyte development, these factors are also important later in the development of NK cells. Id2-deficient mice have a cell-intrinsic lack of peripheral NK cells [13] that was found to be due to an arrest at the iNK stage [14], indicating that Id2 is important in the transition from immature to mature NK cell. Both Id2 and Id3 are expressed in NKP, and Id2
Regulation of effector NK cell responses and memory formation
The STAT family of transcription factors contains members that are phosphorylated downstream of pro-inflammatory cytokine receptors and form homo-dimers or hetero-dimers that translocate to the nucleus to induce gene transcription (reviewed in [80]). During viral infection, type I IFNs and downstream STAT1 have been shown to enhance NK cell cytotoxicity (Figure 3) [81, 82], and shield activated NK cells from cell death via an NKG2D-dependent fratricide mechanism [83•]. IL-12 and downstream
Concluding remarks
As is evident by the number of groundbreaking studies discussed in this review, the development of NK cells is a highly dynamic process and new discoveries occur each week. Still, there is so much we do not yet understand. Future work will elucidate the mechanisms regulating the various factors described above, how the factors interact with each other, and how they might be involved in disease processes.
References and recommended reading
Papers of particular interest, published within the period of review, have been highlighted as:
• of special interest
•• of outstanding interest
Acknowledgements
We thank members of the Sun lab for helpful discussions. In particular we thank Aimee Beaulieu, Clair Geary, and Tim O'Sullivan, who read and commented on this review. We apologize to those whose work we were unable to discuss due to space limitations. TLG is supported by a fellowship from the National Institute of Allergy and Infectious Diseases (F31 AI114019). JCS is supported by the Searle Scholars Program, the Cancer Research Institute, and National Institutes of Health grants AI085034 and
References (96)
- et al.
Identification of clonogenic common lymphoid progenitors in mouse bone marrow
Cell
(1997) - et al.
Tissue-resident natural killer cells and their potential diversity
Semin Immunol
(2014) - et al.
The RAG recombinase dictates functional heterogeneity and cellular fitness in natural killer cells
Cell
(2014) Natural killer cell developmental pathways: a question of balance
Annu Rev Immunol
(2006)- et al.
Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2
Nature
(1999) - et al.
The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation
Immunity
(2012) - et al.
Identification of the earliest natural killer cell-committed progenitor in murine bone marrow
Blood
(2011) - et al.
Identification of the earliest NK-cell precursor in the mouse BM
Blood
(2011) - et al.
PLZF expression maps the early stages of ILC1 lineage development
Proc Natl Acad Sci U S A
(2015) - et al.
Homeostatic control of memory cell progenitors in the natural killer cell lineage
Cell Rep
(2015)
Jagged2 promotes the development of natural killer cells and the establishment of functional natural killer cell lines
Blood
Differential effects of Notch ligands Delta-1 and Jagged-1 in human lymphoid differentiation
J Exp Med
Notch ligands Delta 1 and Jagged1 transmit distinct signals to T-cell precursors
Blood
An essential developmental checkpoint for production of the T cell lineage
Science
Reprogramming of T cells to natural killer-like cells upon Bcl11b deletion
Science
The basic leucine zipper transcription factor NFIL3 directs the development of a common innate lymphoid cell precursor
eLife
Antagonistic role of E4BP4 and PAR proteins in the circadian oscillatory mechanism
Genes Dev
The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells
Nat Immunol
Transcription factor Foxo1 is a negative regulator of natural killer cell maturation and function
Immunity
Interleukin 15-mediated survival of natural killer cells is determined by interactions among Bim, Noxa and Mcl-1
Nat Immunol
IFN regulatory factor-2 deficiency revealed a novel checkpoint critical for the generation of peripheral NK cells
J Immunol
Runx proteins are involved in regulation of CD122, Ly49 family and IFN-gamma expression during NK cell differentiation
Int Immunol
Proinflammatory cytokine signaling required for the generation of natural killer cell memory
J Exp Med
Cutting edge: stage-specific requirement of IL-18 for antiviral NK cell expansion
J Immunol
IL-33 receptor ST2 amplifies the expansion of NK cells and enhances host defense during mouse cytomegalovirus infection
J Immunol
Natural killer cells, bone, and the bone marrow: studies in estrogen-treated mice and in congenitally osteopetrotic (mi/mi) mice
J Immunol
Inhibitory effect on natural killer activity of microphthalmia transcription factor encoded by the mutant mi allele of mice
Blood
Reduced expression of IL-12 receptor beta2 and IL-18 receptor alpha genes in natural killer cells and macrophages derived from B6-mi/mi mice
Lab Invest
Transcriptional control of natural killer cell development and function
Adv Immunol
Identification of committed NK cell progenitors in adult murine bone marrow
Eur J Immunol
Natural killer cells: definition of a cell type rather than a function
J Immunol
Natural killer cell education and tolerance
Cell
The dynamic life of natural killer cells
Annu Rev Immunol
The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development
Nat Immunol
Nfil3/E4bp4 is required for the development and maturation of NK cells in vivo
J Exp Med
IL-4-induced transcription factor NFIL3/E4BP4 controls IgE class switching
Proc Natl Acad Sci U S A
Differential requirement for the transcription factor PU.1 in the generation of natural killer cells versus B and T cells
Blood
Mature natural killer cell and lymphoid tissue-inducing cell development requires Id2-mediated suppression of E protein activity
J Exp Med
Shared dependence on the DNA-binding factor TOX for the development of lymphoid tissue-inducer cell and NK cell lineages
Nat Immunol
T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKT cells
Immunity
TCF-1 upregulation identifies early innate lymphoid progenitors in the bone marrow
Nat Immunol
In vivo developmental stages in murine natural killer cell maturation
Nat Immunol
CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity
J Immunol
Maturation of mouse NK cells is a 4-stage developmental program
Blood
Natural killer cells: walking three paths down memory lane
Trends Immunol
Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection
Immunity
Regulation of lymphoid development, differentiation, and function by the Notch pathway
Annu Rev Immunol
An early T cell lineage commitment checkpoint dependent on the transcription factor Bcl11b
Science
Cited by (103)
Particle radiotherapy in the era of radioimmunotherapy
2023, Cancer LettersInnate lymphoid cells: potential targets for cancer therapeutics
2023, Trends in CancerCitation Excerpt :Until recently, ILCs have been represented by natural killer (NK) cells [12] and LTi cells [13], but this family has now been expanded by the discovery of additional subsets [14]. NK cells have been extensively characterized for their capacity to kill tumor cells and virus-infected cells in the absence of a previous exposure to an antigen [15–17], while LTi cells are recruited to embryonic anlagen where they are crucial for the development of secondary lymphoid tissues (see Glossary). Collectively, ILCs can now be divided into five distinct subsets: NK cells, ILC1s, ILC2s, ILC3s, and LTi cells, which have been defined based on the identification of their lineage-specific progenitor populations [14] (Figure 1).
The immune system
2022, Clinical ImmunologyUnderstanding and improving cellular immunotherapies against cancer: From cell-manufacturing to tumor-immune models
2021, Advanced Drug Delivery Reviews